Ies show that frailty is associated with increased mortality so it is indeed interesting that this audit has shown no difference between the two groups.References 1. Rockwood, Song, McKnight. A global clinical measure of fitness and frailty in elderly people.CMAJ: 2005, vol 173 no.5 2. The Edmonton Frailty Scale. Age and Ageing, volume 35.A940 Outcomes in elderly patients admitted to ICU C. Castro

Aterial, or human data, or used regulated vertebrates or invertebratesResultsBORIS stimulates MAGE-A1 mRNA expression in MCF-7 and BCM1 cellsWe previously demonstrated that the demethylating agent 5-aza-CdR and the histone deacetylase inhibitor TSA synergistically upregulate MAGE-A1 expression in cell lines derived from different cancer types [6]. Moreover, Vatolin et al. reported that conditional

Aterial, or human data, or used regulated vertebrates or invertebratesResultsBORIS stimulates MAGE-A1 mRNA expression in MCF-7 and BCM1 cellsWe previously demonstrated that the demethylating agent 5-aza-CdR and the histone deacetylase inhibitor TSA synergistically upregulate MAGE-A1 expression in cell lines derived from different cancer types [6]. Moreover, Vatolin et al. reported that conditional

Shenzhen Teesso Clothing CO.,LTD, a knitted clothing garments manufacturer, has specialized in T-shirt, polo shirt, vest, football wear, hoodie, sportswear, babies' and children's garments etc since 1998.

Shenzhen Teesso Clothing CO.,LTD, a knitted clothing garments manufacturer, has specialized in T-shirt, polo shirt, vest, football wear, hoodie, sportswear, babies' and children's garments etc since 1998.

T assays were conducted, and the mean percent relative activity is reported (see text). A dose response from a single assay of the three is presented here as representative data. e Representative nonconstrained dose?response curves of ABP 501 (red), adalimumab (US) (black), and adalimumab (EU) (blue) showing binding to FcRn. Each point is a mean of three replicates ?standard deviation. Adalimumab

T assays were conducted, and the mean percent relative activity is reported (see text). A dose response from a single assay of the three is presented here as representative data. e Representative nonconstrained dose?response curves of ABP 501 (red), adalimumab (US) (black), and adalimumab (EU) (blue) showing binding to FcRn. Each point is a mean of three replicates ?standard deviation. Adalimumab

Ies show that frailty is associated with increased mortality so it is indeed interesting that this audit has shown no difference between the two groups.References 1. Rockwood, Song, McKnight. A global clinical measure of fitness and frailty in elderly people.CMAJ: 2005, vol 173 no.5 2. The Edmonton Frailty Scale. Age and Ageing, volume 35.A940 Outcomes in elderly patients admitted to ICU C. Castro